X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Strict-Transport-Security: max-age=63072000; includeSubDomains; preload

Pipeline

EM Imaging portfolio

Edinburgh Molecular Imaging has a portfolio of agents designed to improve detection and treatment of Cancer. All Agents progressed to date have been found to be safe, specific, sensitive and selective.

*Indication to be disclosed at a later stage.
EMI-137 (Optical Agent) was previously known as GE-137. See related publications here.